Filing Details

Accession Number:
0001055726-21-000050
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-11 16:24:37
Reporting Period:
2021-06-09
Accepted Time:
2021-06-11 16:24:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1055726 Inovio Pharmaceuticals Inc. INO Surgical & Medical Instruments & Apparatus (3841) 330969592
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1259780 Peter Kies C/O Inovio Pharmaceuticals, Inc.
6769 Mesa Ridge Road
San Diego CA 92121
Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-09 13,750 $2.16 164,538 No 4 M Direct
Common Stock Disposition 2021-06-09 33,750 $10.01 130,788 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Option Disposition 2021-06-09 13,750 $0.00 13,750 $2.16
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 2013-03-14 2023-03-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,500 Indirect By Spouse
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. These transactions were executed in multiple trades at prices ranging from $10.00 to $10.04, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.